Tranexamic acid lowers transfusion requirements and hospital length of stay following revision total hip or knee arthroplasty

BACKGROUD: Intravenous tranexamic acid (TXA) has been shown to reduce blood loss in patients undergoing total joint arthroplasty without systemic complications. There is limited evidence of its effectiveness in revision procedures. This study evaluated intravenous TXA effect on blood loss, transfusi...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Patient Saf Surg
Päätekijät: Gianakos, Arianna L., Saad, Bishoy N., Haring, Richard, Menken, Luke G., Elkattaway, Sherif, Liporace, Frank A., Yoon, Richard S.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2021
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8111901/
https://ncbi.nlm.nih.gov/pubmed/33975621
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13037-021-00295-5
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia